Alan J Korman Selected Research

Alan J Korman Research Topics

Disease

51	Neoplasms (Cancer) 10/2022 - 01/2006
15	Melanoma (Melanoma, Malignant) 01/2023 - 10/2007
5	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 07/2010
4	Infections 01/2018 - 01/2013
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 07/2010
3	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 07/2010
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 07/2010
3	Glioma (Gliomas) 11/2020 - 01/2019
3	Multiple Myeloma 05/2017 - 07/2012
2	Inflammation (Inflammations) 01/2021 - 01/2016
2	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2020
2	Sarcoma (Soft Tissue Sarcoma) 01/2017 - 11/2014
2	Body Weight (Weight, Body) 07/2013 - 06/2012
1	Ovarian Neoplasms (Ovarian Cancer) 11/2020
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Diarrhea 01/2018
1	Facial Paralysis (Facial Palsy) 01/2018
1	Viremia 01/2018
1	Carcinoma (Carcinomatosis) 09/2015
1	Stomach Neoplasms (Stomach Cancer) 07/2013
1	Colonic Neoplasms (Colon Cancer) 07/2013
1	Fungemia 05/2013
1	Mycoses (Diseases, Fungus) 05/2013
1	Sepsis (Septicemia) 05/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2013
1	Lymphoid Leukemia 01/2013
1	Disease Progression 01/2013
1	Chronic Hepatitis C 01/2013
1	Virus Diseases (Viral Diseases) 01/2013
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2012

Drug/Important Bio-Agent (IBA)

12	LigandsIBA 11/2019 - 04/2010
10	Monoclonal AntibodiesIBA 01/2021 - 01/2013
9	IpilimumabIBA 01/2022 - 07/2013
9	AntibodiesIBA 01/2021 - 04/2006
8	Immune Checkpoint InhibitorsIBA 10/2022 - 09/2015
7	NivolumabIBA 10/2022 - 01/2013
6	AntigensIBA 01/2021 - 04/2006
4	VaccinesIBA 01/2020 - 10/2007
3	Peptides (Polypeptides)IBA 01/2022 - 10/2007
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2015
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 05/2015
3	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 05/2017
3	ChemokinesIBA 01/2021 - 05/2017
3	urelumabIBA 01/2021 - 09/2015
3	Immunoconjugates (Immunoconjugate)IBA 11/2020 - 01/2019
3	CTLA-4 AntigenIBA 01/2019 - 07/2013
3	CytokinesIBA 01/2018 - 01/2016
3	Programmed Cell Death 1 ReceptorIBA 09/2015 - 07/2013
2	Dihydrotachysterol (AT 10)IBA 01/2023 - 07/2010
2	Interleukin-2 (IL2)IBA 01/2022 - 01/2018
2	Interferon-gamma (Interferon, gamma)IBA 11/2020 - 05/2013
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2019
2	Antinuclear AntibodiesIBA 01/2018 - 04/2010
2	Immunoglobulin G (IgG)IBA 01/2018 - 07/2013
2	Therapeutic UsesIBA 01/2018 - 08/2009
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 02/2015
2	Protein Subunit VaccinesIBA 12/2015 - 11/2014
2	EpitopesIBA 11/2014 - 01/2006
1	relatlimabIBA 10/2022
1	MucinsIBA 01/2022
1	InterferonsIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Chemokine ReceptorsIBA 01/2021
1	Interleukin-15 (Interleukin 15)IBA 10/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	malic acid (malate)IBA 01/2019
1	Dasatinib (BMS 354825)FDA Link 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Biopolymers (Biopolymer)IBA 01/2019
1	PolymersIBA 01/2019
1	Chemotactic FactorsIBA 10/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018
1	OvalbuminIBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	Conditioned Culture MediaIBA 01/2018
1	HLA-DR Antigens (HLA-DR)IBA 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018
1	elotuzumabIBA 05/2017
1	OligodeoxyribonucleotidesIBA 01/2017
1	MethylcholanthreneIBA 01/2017
1	interleukin-21 (interleukin 21)IBA 01/2017
1	Interleukin-12 (IL 12)IBA 11/2016
1	Interleukin-10 (Interleukin 10)IBA 02/2015
1	Indicators and Reagents (Reagents)IBA 02/2015
1	Mutant Proteins (Protein, Mutant)IBA 11/2014
1	ulocuplumabIBA 01/2013
1	Antiviral Agents (Antivirals)IBA 01/2013
1	Minor Histocompatibility AntigensIBA 07/2012

Therapy/Procedure

22	Therapeutics 01/2023 - 01/2006
22	Immunotherapy 01/2022 - 01/2006
3	Castration 01/2021 - 06/2012
2	Intravenous Infusions 01/2023 - 07/2010
1	Drug Therapy (Chemotherapy) 01/2022
1	Neoadjuvant Therapy 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 01/2021
1	Radiotherapy 10/2018
1	Punctures 05/2013
1	Ligation 05/2013